The Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins
At Swim Across
America, we are dedicated to our beneficiaries and the work that they do and we
could not be prouder to have SKCCC on the list of world-renowned
institutions that we support. We are especially thrilled to have a dedicated
cancer research laboratory named after Swim Across America at SKCCC.
inception in 1973, The SKCCC has become one of the most prestigious
and advanced cancer centers in the world. Dedicated to understanding human
cancer and finding more effective treatments, their scientists were the first
to map a cancer genome, deciphering the genetic blueprints for colon, breast,
pancreatic, and brain cancers. Johns Hopkins Kimmel Cancer Center
scientists have cracked the genetic code of more than 10 different forms of
cancer, more than any other research team in the world - These discoveries have
paved the way for personalized therapies. Among its many ground-breaking
achievements, Kimmel Cancer Center researchers were among the first to perform
bone marrow transplants to treat blood and immune-forming cancers and also were
among the first to develop therapeutic cancer vaccines.
and Patient Care
SKCCC has not
only shown excellence in the research and development of cancer treatments, but
also in patient care. Because Kimmel Cancer Center research scientists and
clinicians work closely together, new drugs and treatments developed in the
laboratory are quickly transferred to the clinical setting, offering patients
constantly improved therapeutic options. Patients who visit the Kimmel Cancer
Center have access to some of the most innovative and advanced therapies in the
The Kimmel Cancer
Center also offers complete family and patient services that include a Cancer
Counseling Center, survivors and palliative care programs, and the 39 suite,
Hackerman-Patz Patient and Family Pavilion for patients and their families
traveling from out of town.
Experience the Johns Hopkins Kimmel Cancer Center by taking a virtual
tour of the clinical care building. "Walk" through
their facilities to learn more about services and programs.
from the Swim Across America Laboratory at Johns Hopkins
the Swim Across America Laboratory at Johns Hopkins, scientists recently
received worldwide attention for developing a genomic-based test for ovarian
and endometrial cancers, using fluid collected from routine pap tests. The new
test, called PapGene, is undergoing further testing, but promises to pioneer
the use of genomic-based screening tests.
in the Swim Across America-funded laboratory also completed genomic sequencing
studies in brain, ovarian, and endometrial cancers, as well as pediatric
neuroblastomas and pancreatic cysts, which are precursors to pancreatic cancer.
From these extensive genomic studies, scientists discover more information
about how cancers develop and thrive in patients. This information fuels
additional studies on new targets for more effective treatments and better
tumor biobank, a repository of tissue samples being developed with the Ludwig
Center at Johns Hopkins, also helps scientists test their experiments on vast
quantities of tumor samples. Clinical testing in cancer patients includes
a trial of frequent, low doses of chemotherapy combinations in pancreatic
cancer and a study using tumor necrosis factor, which is used to treat
inflammatory diseases, as a way to boost delivery of nanoparticles filled with
anticancer drugs to tumors.
cancer patients at Johns Hopkins also benefit from a Swim Across America-funded
survivorship clinic that tracks patients’ continuing needs and health and a
“couples retreat” provided free-of-charge to patients with metastatic